In summary, aaptamine selectively represses cell cycle regulation drivers (CDK2/4 and Cyclin D1/E) and the upstream regulator cascades (PI3K/AKT/GSK3β) to retard the cell proliferation and invasive growth of NSCLC cells. Here, AKT1 is linked to non-small cell lung carcinoma.